These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance. Bergström R. Drug Resist Updat; 2011 Apr; 14(2):77-8. PubMed ID: 21493123 [Abstract] [Full Text] [Related]
4. Time for a change: addressing R&D and commercialization challenges for antibacterials. Payne DJ, Miller LF, Findlay D, Anderson J, Marks L. Philos Trans R Soc Lond B Biol Sci; 2015 Jun 05; 370(1670):20140086. PubMed ID: 25918443 [Abstract] [Full Text] [Related]
9. The urgent need for new antibacterial agents. Wise R, BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development. J Antimicrob Chemother; 2011 Sep 05; 66(9):1939-40. PubMed ID: 21700627 [No Abstract] [Full Text] [Related]
12. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges. Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H. Curr Opin Microbiol; 2004 Oct 05; 7(5):445-50. PubMed ID: 15451498 [Abstract] [Full Text] [Related]
14. Antibacterial drug discovery: is it all downhill from here? Projan SJ, Shlaes DM. Clin Microbiol Infect; 2004 Nov 05; 10 Suppl 4():18-22. PubMed ID: 15522036 [Abstract] [Full Text] [Related]
16. Antibiotic research and development: business as usual? Harbarth S, Theuretzbacher U, Hackett J, DRIVE-AB consortium. J Antimicrob Chemother; 2015 Nov 05; 70(6):1604-7. PubMed ID: 25673635 [Abstract] [Full Text] [Related]